HOUSE DOCKET, NO. 3387        FILED ON: 2/19/2021

HOUSE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 2403

 

The Commonwealth of Massachusetts

_________________

PRESENTED BY:

Jon Santiago

_________________

To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:

The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:

An Act to establish a sharps stewardship program.

_______________

PETITION OF:

 

Name:

District/Address:

Date Added:

Jon Santiago

9th Suffolk

2/11/2021

Chynah Tyler

7th Suffolk

2/26/2021

James J. O'Day

14th Worcester

2/26/2021

Paul McMurtry

11th Norfolk

2/26/2021


HOUSE DOCKET, NO. 3387        FILED ON: 2/19/2021

HOUSE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 2403

By Mr. Santiago of Boston, a petition (accompanied by bill, House, No. 2403) of Jon Santiago and others relative to the definition of "covered drug" under the program financed by pharmaceutical product manufacturers or groups of manufacturers to collect, secure, transport and safely dispose of unwanted drugs.  Public Health.

 

The Commonwealth of Massachusetts

 

_______________

In the One Hundred and Ninety-Second General Court
(2021-2022)

_______________

 

An Act to establish a sharps stewardship program.

 

Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows:
 

SECTION 1. Section 1 of chapter 94H of the General Laws, as so appearing, is hereby amended

by striking out the second paragraph and inserting in place thereof the following paragraph:-

“Covered drug”, any brand name or generic opioid drug placed in Schedule II or Schedule III of

section 3 of chapter 94C; provided, however, that “covered drug” shall also include

benzodiazepines; provided, further, that “covered drug” shall not include: (i) drugs intended for

use solely in veterinary care; (ii) substances that are regulated as cosmetic products under the

United States Food, Drug and Cosmetic Act, 21 U.S.C. § 301 et seq.; or (iii) drugs that are

compounded under a specialty license pursuant to sections 39G to 39J, inclusive, of chapter 112.

SECTION 2. Section 55 of chapter 52 of the acts of 2016, as amended by section 6 of chapter

351 of the acts of 2016, is hereby repealed.

SECTION 3. Section 77 of chapter 52 of the acts of 2016, is hereby repealed.